Tonazocine (WIN-42156) is an opioid analgesic of the benzomorphan family which made it to phase II clinical trials for the treatment of postoperative pain but development was apparently ceased and ultimately it was never marketed. Tonazocine is a partial agonist at both the mu-opioid and delta-opioid receptors but acting more like an antagonist at the former and more like an agonist at the latter.
This page contains content from the copyrighted Wikipedia article "Tonazocine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
